Literature DB >> 15087386

Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate.

Masao Furuhashi1, Tobias Sjöblom, Alexandra Abramsson, Jens Ellingsen, Patrick Micke, Hong Li, Erika Bergsten-Folestad, Ulf Eriksson, Rainer Heuchel, Christer Betsholtz, Carl-Henrik Heldin, Arne Ostman.   

Abstract

Platelet-derived growth factor (PDGF) receptor signaling participates in different processes in solid tumors, including autocrine stimulation of tumor cell growth, recruitment of tumor stroma fibroblasts, and stimulation of tumor angiogenesis. In the present study, the B16 mouse melanoma tumor model was used to investigate the functional consequences of paracrine PDGF stimulation of host-derived cells. Production of PDGF-BB or PDGF-DD by tumor cells was associated with an increased tumor growth rate. Characterization of tumors revealed an increase in pericyte abundance in tumors derived from B16 cells producing PDGF-BB or PDGF-DD. The increased tumor growth rate associated with PDGF-DD production was not seen in mice expressing an attenuated PDGF beta-receptor and was thus dependent on host PDGF beta-receptor signaling. The increased pericyte abundance was not associated with an increased tumor vessel density. However, tumor cell apoptosis, but not proliferation, was reduced in tumors displaying PDGF-induced increased pericyte coverage. Our findings thus demonstrate that paracrine PDGF production stimulates pericyte recruitment to tumor vessels and suggest that pericyte abundance influences tumor cell apoptosis and tumor growth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15087386     DOI: 10.1158/0008-5472.can-03-1489

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  62 in total

1.  Loss of Pericytes in Radiation Necrosis after Glioblastoma Treatments.

Authors:  Soon-Tae Lee; Youngbeom Seo; Ji-Yeon Bae; Kon Chu; Jin Wook Kim; Seung Hong Choi; Tae Min Kim; Il Han Kim; Sung-Hye Park; Chul-Kee Park
Journal:  Mol Neurobiol       Date:  2017-08-02       Impact factor: 5.590

2.  Molecular cloning of the human platelet-derived growth factor receptor beta (PDGFR-beta) promoter and drug targeting of the G-quadruplex-forming region to repress PDGFR-beta expression.

Authors:  Yong Qin; Jessica S Fortin; Denise Tye; Mary Gleason-Guzman; Tracy A Brooks; Laurence H Hurley
Journal:  Biochemistry       Date:  2010-05-18       Impact factor: 3.162

3.  Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102.

Authors:  Barbara Sennino; Beverly L Falcón; Dilara McCauley; Tom Le; Thomas McCauley; Jeffrey C Kurz; Amy Haskell; David M Epstein; Donald M McDonald
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

Review 4.  Role of platelet-derived growth factors in physiology and medicine.

Authors:  Johanna Andrae; Radiosa Gallini; Christer Betsholtz
Journal:  Genes Dev       Date:  2008-05-15       Impact factor: 11.361

5.  A digest on the role of the tumor microenvironment in gastrointestinal cancers.

Authors:  Martin Augsten; Christina Hägglöf; Cristina Peña; Arne Ostman
Journal:  Cancer Microenviron       Date:  2010-03-07

6.  The Consequences of Overlapping G-Quadruplexes and i-Motifs in the Platelet-Derived Growth Factor Receptor β Core Promoter Nuclease Hypersensitive Element Can Explain the Unexpected Effects of Mutations and Provide Opportunities for Selective Targeting of Both Structures by Small Molecules To Downregulate Gene Expression.

Authors:  Robert V Brown; Ting Wang; Venkateshwar Reddy Chappeta; Guanhui Wu; Buket Onel; Reena Chawla; Hector Quijada; Sara M Camp; Eddie T Chiang; Quinea R Lassiter; Carmen Lee; Shivani Phanse; Megan A Turnidge; Ping Zhao; Joe G N Garcia; Vijay Gokhale; Danzhou Yang; Laurence H Hurley
Journal:  J Am Chem Soc       Date:  2017-05-19       Impact factor: 15.419

7.  Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis.

Authors:  Harald Krenzlin; Prajna Behera; Viola Lorenz; Carmela Passaro; Mykola Zdioruk; Michal O Nowicki; Korneel Grauwet; Hong Zhang; Magdalena Skubal; Hirotaka Ito; Rachel Zane; Michael Gutknecht; Marion B Griessl; Franz Ricklefs; Lai Ding; Sharon Peled; Arun Rooj; C David James; Charles S Cobbs; Charles H Cook; E Antonio Chiocca; Sean E Lawler
Journal:  J Clin Invest       Date:  2019-03-11       Impact factor: 14.808

8.  Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma.

Authors:  David A Reardon; Annick Desjardins; James J Vredenburgh; Sith Sathornsumetee; Jeremy N Rich; Jennifer A Quinn; Theodore F Lagattuta; Merrill J Egorin; Sridharan Gururangan; Roger McLendon; James E Herndon; Allan H Friedman; August J Salvado; Henry S Friedman
Journal:  Neuro Oncol       Date:  2008-03-21       Impact factor: 12.300

9.  Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer.

Authors:  Janna Paulsson; Tobias Sjöblom; Patrick Micke; Fredrik Pontén; Göran Landberg; Carl-Henrik Heldin; Jonas Bergh; Donal J Brennan; Karin Jirström; Arne Ostman
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

10.  LIM-homeobox gene 2 promotes tumor growth and metastasis by inducing autocrine and paracrine PDGF-B signaling.

Authors:  Aleksandar Kuzmanov; Ulrike Hopfer; Patricia Marti; Nathalie Meyer-Schaller; Mahmut Yilmaz; Gerhard Christofori
Journal:  Mol Oncol       Date:  2013-12-25       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.